글로벌 시알라데니티스 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력 : 글로벌 시알라데니티스 시장

2021년부터 2028년까지의 예측 기간 동안 습진 시장은 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에 언급된 예측 기간 동안 시장이 4%의 CAGR로 성장할 것으로 분석합니다.

침샘염은 침샘염 또는 침샘 감염이라고도 합니다. 박테리아나 바이러스에 의해 유발되는 염증으로 인해 침샘관이 막힙니다. 얼굴 옆, 귀 근처의 이하선 침샘과 턱 아래의 턱밑 침샘에 가장 흔히 영향을 미칩니다. 통증, 열, 오한, 입안 고름, 피부 발적, 통증, 영향을 받는 부위 주변의 붓기가 침샘염의 증상입니다. 노인과 만성 질환자에게 가장 흔히 영향을 미치며, 특히 입이 마르거나 탈수된 사람에게 영향을 미칩니다.

시알라데니스 유병률의 증가와 당뇨병 , 식욕 부진, 류마티스 관절염 및 신부전과 같은 생활 습관 장애의 증가. 이 모든 것이 타액의 흐름을 감소시키고 타액선 감염을 유발하여 시알라데니스 시장 성장을 촉진합니다. 또한 의료비 지출 증가, 흡연, 알코올 남용 증가, 입, 머리 또는 목의 화학 요법 또는 방사선 요법의 급증, 노인 인구 증가는 시알라데니스 시장을 확대할 요인입니다.

연구 개발 활동이 증가하고 예방 조치에 대한 인식이 높아지면 2021~2028년 예측 기간 동안 안와선염 시장에 유익한 기회가 제공될 것입니다.

그러나 높은 치료 비용과 농양 형성, 피부 누공 발생, 세균 감염의 국소적 확산 등 감염과 관련된 합병증은 시장 성장을 방해하는 요소이며, 위에서 언급한 예측 기간 동안 낭선염 시장을 더욱 어렵게 만들 것입니다.

This sialadenitis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the sialadenitis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Sialadenitis Market Scope and Market Size

The sialadenitis market is segmented on the basis of type, treatment, diagnosis, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the sialadenitis market is segmented into acute sialadenitis, chronic sialadenitis and granulomatous sialadenitis.
• On the basis of treatment, the sialadenitis market is segmented into antibiotic, surgery, warm compresses, massage and others.
• On the basis of diagnosis, the sialadenitis market is segmented into ultrasound, CT scan, MRI, sialoendoscopy and others.
• On the basis of route of administration, the sialadenitis market is segmented into intravenous and others.
• On the basis of end-users, the sialadenitis market is segmented into clinic, hospital and others.

The sialadenitis market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Sialadenitis Market Country Level Analysis

Sialadenitis market is analyzed and market size information is provided by the country, type, treatment, diagnosis, route of administration, end-users and distribution channel as referenced above.

The countries covered in the sialadenitis market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the sialadenitis market due to the presence of major key players, high disposable income, high healthcare expenditure and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Sialadenitis market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Sialadenitis Market Share Analysis

Sialadenitis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to sialadenitis market research.

시알라데니스 시장 보고서에 포함된 주요 기업으로는 Allergan, Merck Sharp & Dohme Corp., Pfizer Inc., GlaxoSmithKline plc, Melinta Therapeutics LLC, Basilea Pharmaceutica Ltd., Tetraphase Pharmaceuticals, Paratek Pharmaceuticals, Inc., Nabriva Therapeutics plc, Spero Therapeutics, Abbott, F. Hoffmann-La Roche Ltd., Mylan NV, Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Bayer AG, Sun Pharmaceutical Industries Ltd., Lilly, Aurobindo Pharma, Lupin, SHIONOGI & Co., Ltd., AbbVie Inc., Cumberland Pharmaceuticals Inc. 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-66434